Ubs Asset Management Americas Inc Sana Biotechnology, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 279,282 shares of SANA stock, worth $645,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
279,282
Previous 253,899
10.0%
Holding current value
$645,141
Previous $1.06 Million
56.91%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SANA
# of Institutions
178Shares Held
122MCall Options Held
1.77MPut Options Held
901K-
Flagship Pioneering Inc. Cambridge, MA25MShares$57.8 Million12.19% of portfolio
-
Black Rock Inc. New York, NY11MShares$25.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$24.8 Million0.0% of portfolio
-
Baillie Gifford & CO10.2MShares$23.6 Million0.01% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$23.5 Million0.02% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $439M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...